Table 2.

Correlation of OAS-LPD subgroups with genetic alterations in The Cancer Genome Atlas Dataset.

	TCGA			CancerMap			CamCap
	ETS–	ETS+	χ2 P-val	ERG–	ERG+	χ2 P-val	ERG–	ERG+	χ2 P-val
LPD1	8	3	0.0588	13	4	0.0851	0	3	0.235
LPD2	4	8	0.827	3	3	1	0	2	0.467
LPD3	9	67	1.45 × 10−08	5	15	0.00977	4	17	0.00299
LPD4	14	21	1	14	15	0.619	1	2	0.987
LPD5	65	5	2.20 × 10−16	19	1	0.000180	34	0	1.15 × 10−11
LPD6	13	22	0.802	5	5	1	2	4	0.657
DESNT	13	66	1.17 × 10−06	6	15	0.0207	9	24	0.00274
LPD8	9	6	0.193	8	4	0.540	4	1	0.371

	PTEN			SPOP			CHD1
	Non-homdel	Homdel	χ2 P-val	Non-mut	Mut	χ2 P-val	Non-homdel	Homdel	χ2 P-val
LPD1	10	1	0.896	8	3	0.213	9	2	0.309
LPD2	12	0	0.284	12	0	0.436	12	0	0.756
LPD3	55	21	0.000894	73	3	0.0400	76	0	0.0211
LPD4	35	0	0.0174	31	4	1	34	1	0.603
LPD5	67	3	0.00830	51	19	4.46 × 10−06	57	13	7.69 × 10−06
LPD6	29	6	0.903	32	3	0.825	34	1	0.603
DESNT	60	19	0.0167	75	4	0.0795	76	3	0.432
LPD8	15	0	0.195	14	1	0.889	14	1	1

Statistically significant differences are italicised.